Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and showing a generic error screen instead of the usual content. This indicates an access or permissions problem rather than an update to the study information.SummaryDifference22%

- Check46 days agoChange DetectedThe page shows an updated revision tag: from v3.6.5 to v3.6.6, indicating a deployment of the latest site template. The change does not modify study content or user-facing functionality.SummaryDifference0.0%

- Check68 days agoChange DetectedA new Revision: v3.6.5 tag is added. Several policy-related sections and study documents were removed from the page.SummaryDifference21%

- Check82 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision. This is an internal version update and does not change the study content or how the page works.SummaryDifference0.0%

- Check103 days agoChange DetectedRevision label on the page updated from v3.6.2 to v3.6.3, reflecting a newer site build.SummaryDifference0.0%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.